Development of a universal flu vaccine has been a long-sought goal, and as flu scientists begin to see light at the end of a decades-long tunnel, encouraging data have emerged on an experimental shot. It appears effective ...
Since the first reports of HIV infection in the early 1980s, multiple clinical trials have tested potential vaccines against the virus, but unfortunately, HIV has numerous defense mechanisms that prevent a person's immune ...
Apr 11, 2022
0
58
An international consortium co-led by Vanderbilt University Medical Center immunogeneticist Rubén Martínez-Barricarte, Ph.D., has discovered a new genetic disorder that causes immunodeficiency and profound susceptibility ...
Jan 21, 2023
0
68
You've gone through the appointment rigmarole to get signed up for a COVID vaccine, got your first shot, waited the required three to four week period for your second. But when that booster dose comes, be warned that you ...
Mar 1, 2021
0
3
Yale clinicians report promising results after treating COVID-19 patients at Yale New Haven Hospital (YNHH) with a drug that reduces hyperinflammation in cancer patients undergoing immunotherapy.
Jun 19, 2020
0
56
New modeling of typhus infections in the Warsaw Ghetto during WWII reveals how public health interventions eradicated the disease.
Jul 24, 2020
0
398
Adults with obesity are more susceptible to influenza A/H1N1pdm—the swine flu virus, according to a new study that did not, however, find a similar association with the seasonal flu.
Jul 10, 2020
0
363
Two years after COVID-19 emerged, researchers have provided three cost-effective actions to help decision-makers prevent future pandemics by stopping "spillover" of diseases from animals into humans: better surveillance of ...
Feb 4, 2022
5
243
A new study led by Luís Graça, group leader at the Instituto de Medicina Molecular João Lobo Antunes (iMM, Lisbon) and full professor at the Medical School of the University of Lisbon, and Manuel Carmo Gomes, associate ...
Jan 6, 2023
1
83
(HealthDay)—Two COVID-19 vaccines are on the verge of approval in the United States, with pharmaceutical companies promising that millions of doses will be available to the first wave of recipients within a matter of weeks.
Dec 4, 2020
0
8
